SPARCL: Atorvastatin Stroke Benefit Reinforced in New Analysis SPARCL: Atorvastatin Stroke Benefit Reinforced in New Analysis
A new analysis of the SPARCL trial has shown that the total number of vascular events prevented with atorvastatin was more than twice the number of first events prevented.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - March 23, 2020 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

FDA Approves Non-Statin Drug That Lowers Cholesterol
TRENTON, N.J. (AP) — U.S. regulators on Friday approved a new type of cholesterol-lowering drug aimed at millions of people who can’t tolerate — or don’t get enough help from — widely used statin pills like Lipitor and Crestor. The Food and Drug Administration approved Esperion Therapeutics Inc.’s Nexletol for people genetically predisposed to have sky-high cholesterol and people who have heart disease and need to further lower their bad cholesterol. The daily pill is to be taken in conjunction with a healthy diet and the highest statin dose patients can handle, the FDA said. High LDL, o...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 24, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston Cholesterol Statins Source Type: news

FDA approves drug that lowers cholesterol in a new way
U.S. regulators have approved a new type of cholesterol-lowering drug aimed at millions of people who don't get enough help from widely used statin pills like Lipitor and Crestor (Source: ABC News: Health)
Source: ABC News: Health - February 22, 2020 Category: Consumer Health News Tags: Health Source Type: news

Coronavirus: Niti CEO to find ways to reduce drug import dependence on China
The list has been compiled by the drug regulatory authority and contains antibiotics like azithromycin, amoxicillin, ofloxacin, metronidazole, vitamins such as B12, B1, B6 and E, female hormone progesterone and anticardiac arrest drug atorvastatin, among others. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 20, 2020 Category: Pharmaceuticals Source Type: news

Is That Statin Doing You Any Good?
THURSDAY, Oct. 17, 2019 -- Many people who take cholesterol-lowering statins may not benefit from them, researchers say. Drugs like atorvastatin (Lipitor) and fluvastatin (Lescol) provide little value to people without heart disease, new research... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 17, 2019 Category: General Medicine Source Type: news

Medical News Today: What are the side effects of Lipitor? An overview
Lipitor is a cholesterol lowering statin that has a low risk of side effects. Learn about its side effects, warnings, and possible drug interactions here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 2, 2019 Category: Consumer Health News Tags: Statins Source Type: news

Retiring CEO Bresch leaves a legacy of growth at Mylan
Global pharmaceutical company Mylan NV announced its CEO and Board Director Heather Bresch will retire as the company merges with Pfizer Inc. unit Upjohn by the middle of 2020 to form a new company with the EpiPen, Lipitor and Viagra among its products. In 2012, Bresch was the first woman named CEO of a Fortune 500 global pharmaceutical company. During an almost three-decade career at Mylan, she helped transform the company from a 300-employee, $100 million revenue, single-country operation into… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 29, 2019 Category: Pharmaceuticals Authors: Anne Stych Source Type: news

Pfizer in talks to merge off-patent assets with Mylan
Deal would create large seller of drugs including former blockbuster brands Lipitor and Viagra (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 27, 2019 Category: Pharmaceuticals Source Type: news

Pfizer and Mylan in talks to merge off-patent drugs operations
Stock deal would create large seller of products including former blockbusters Lipitor and Viagra (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 27, 2019 Category: Pharmaceuticals Source Type: news

Pfizer and Mylan set to merge off-patent drugs operations
Stock deal will create large seller of products including former blockbusters Lipitor and Viagra (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 27, 2019 Category: Pharmaceuticals Source Type: news

Pfizer focuses on regional China after price cuts hit sales
Tendering scheme in 11 cities squeezes out anti-cholesterol drug Lipitor (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 30, 2019 Category: Pharmaceuticals Source Type: news

How Some Generic Drugs Could Do More Harm Than Good
For the 16 years that Dr. Brian Westerberg, a Canadian surgeon, worked volunteer missions at the Mulago National Referral Hospital in Kampala, Uganda, scarcity was the norm. The patients usually exceeded the 1,500 allotted beds. Running water was once cut off when the debt-ridden hospital was unable to pay its bills. On some of his early trips, Westerberg even brought over drugs from Canada in order to treat patients. But as low-cost generics made in India and China became widely available through Uganda’s government and international aid agencies in the early 2000s, it seemed at first like the supply issue had been ...
Source: TIME: Health - May 17, 2019 Category: Consumer Health News Authors: Katherine Eban Tags: Uncategorized generic drugs medication medicine Source Type: news

Lipitor (atorvastatin) vs. Vytorin (simvastatin and ezetimibe)
Title: Lipitor (atorvastatin) vs. Vytorin (simvastatin and ezetimibe)Category: MedicationsCreated: 5/17/2019 12:00:00 AMLast Editorial Review: 5/17/2019 12:00:00 AM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - May 17, 2019 Category: Cardiology Source Type: news

Lipitor (atorvastatin) vs. Zetia (ezetimibe)
Title: Lipitor (atorvastatin) vs. Zetia (ezetimibe)Category: MedicationsCreated: 5/17/2019 12:00:00 AMLast Editorial Review: 5/17/2019 12:00:00 AM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - May 17, 2019 Category: Cardiology Source Type: news

Lipitor (atorvastatin) vs. Niacin (nicotinic acid, vitamin B3)
Title: Lipitor (atorvastatin) vs. Niacin (nicotinic acid, vitamin B3)Category: MedicationsCreated: 5/17/2019 12:00:00 AMLast Editorial Review: 5/17/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - May 17, 2019 Category: Cardiology Source Type: news

Lipitor (atorvastatin) vs. Crestor (rosuvastatin)
Title: Lipitor (atorvastatin) vs. Crestor (rosuvastatin)Category: MedicationsCreated: 5/15/2019 12:00:00 AMLast Editorial Review: 5/15/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - May 15, 2019 Category: Cardiology Source Type: news

Statins Safe, Effective in Rheumatoid Arthritis Patients
FRIDAY, April 19, 2019 -- Daily atorvastatin is safe for the primary prevention of cardiovascular events (CVE) in patients with rheumatoid arthritis, conferring a similar degree of risk reduction in these patients as in other populations, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 19, 2019 Category: Pharmaceuticals Source Type: news

Drug used to control cholesterol found effective against cancer-associated cachexia
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) Experiments with mice suggest that treatment with atorvastatin can attenuate adipose tissue remodeling, leading to rapid weight loss and muscle atrophy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 19, 2019 Category: International Medicine & Public Health Source Type: news

Cholesterol-lowering drugs have serious side effects that include brain damage
(Natural News) One out of every five Americans has been convinced to take a statin drug in order to lower their blood cholesterol levels and supposedly prevent heart disease. The Centers for Disease Control (CDC) admit that statin drug use is on the rise; Atorvastatin (Lipitor) is the best-selling prescription drug in the world. The... (Source: NaturalNews.com)
Source: NaturalNews.com - February 20, 2019 Category: Consumer Health News Source Type: news

Zydus receives final approvals from USFDA for skin ointment, heart medicine
The group also received a final nod for Amlodipine and Atorvastatin Tablets USP that is administered for heart and cholesterol-related cases. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 12, 2019 Category: Pharmaceuticals Source Type: news

Why the risks and benefits of statins are so complex
Statin side effects can vary depending on your age, sex and type of statin, when the cholesterol-lowering drugs are used to prevent cardiovascular disease, a new study suggests. Atorvastatin and rosuvastatin provided benefits at a lower 10-year risk. (Source: CNN.com - Health)
Source: CNN.com - Health - December 3, 2018 Category: Consumer Health News Source Type: news

Onset of Musculoskeletal Adverse Events Varies Between Statins
MONDAY, Nov. 19, 2018 -- The onset of musculoskeletal adverse events (MAEs) during statin monotherapy is significantly faster with use of atorvastatin and rosuvastatin versus simvastatin, according to a study published online Nov. 7 in Pharmacology... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 19, 2018 Category: Pharmaceuticals Source Type: news

New Studies Give Mixed Results About Taking Fish Oil and Vitamin D
(CHICAGO) — Taking fish oil or vitamin D? Big studies give long-awaited answers on who does and does not benefit from these popular nutrients. Fish oil taken by healthy people, at a dose found in many supplements, showed no clear ability to lower heart or cancer risks. Same for vitamin D. But higher amounts of a purified, prescription fish oil slashed heart problems and heart-related deaths among people with high triglycerides, a type of fat in the blood, and other risks for heart disease. Doctors cheered the results and said they could suggest a new treatment option for hundreds of thousands of patients like these. ...
Source: TIME: Health - November 10, 2018 Category: Consumer Health News Authors: MARILYNN MARCHIONE / AP Tags: Uncategorized onetime Supplements Source Type: news

Australian watchdog's appeal against Pfizer ruling dismissed by court
Australia's competition watchdog said on Friday the High Court dismissed its special leave application to appeal a court's decision on whether Pfizer Inc's local unit used its market power to limit competition for its cholesterol-lowering drug Lipitor. (Source: Reuters: Health)
Source: Reuters: Health - October 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Court dismisses Australian watchdog's appeal against Pfizer ruling
Australia's competition watchdog said on Friday the High Court dismissed its special leave application to appeal a court's decision on whether Pfizer Inc's local unit used its market power to limit competition for its cholesterol-lowering drug Lipitor. (Source: Reuters: Health)
Source: Reuters: Health - October 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Statins: Any Benefit in Knee OA?
(MedPage Today) -- Only after 5 years of use, and with atorvastatin (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - August 30, 2018 Category: Primary Care Source Type: news

Atorvastatin Calcium Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 2, 2018 Category: Drugs & Pharmacology Source Type: news

Can a Statin Treat Chronic Subdural Hematoma? (CME/CE)
(MedPage Today) -- Chinese trial shows atorvastatin decreased volume, improved neurologic function (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - July 30, 2018 Category: Neurology Source Type: news

Rhabdomyolysis and AKI Following Atorvastatin-Gemfibrozil Rhabdomyolysis and AKI Following Atorvastatin-Gemfibrozil
This case report demonstrates that severe rhabdomyolysis due to statins with or without fibrates may occur with few clinical symptoms and signs, even many weeks after discontinuation of therapy.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 4, 2018 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Australian watchdog appeals to high court on Pfizer's alleged abuse of market power
MELBOURNE (Reuters) - Australia's competition watchdog said on Monday it would appeal to the nation's high court for a ruling on whether Pfizer Inc used its market power to limit competition for its cholesterol-lowering drug Lipitor. (Source: Reuters: Health)
Source: Reuters: Health - June 25, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Australian anti-trust watchdog loses appeal against Pfizer over Lipitor sales
MELBOURNE (Reuters) - An Australian court dismissed an appeal by the nation's anti-trust watchdog in a case against Pfizer Inc in which the regulator alleged the company had used its market power to limit competition for its cholesterol-lowering drug Lipitor. (Source: Reuters: Health)
Source: Reuters: Health - May 25, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Gene study spots clues to heart risk for statin patients
(Vanderbilt University Medical Center) A Vanderbilt-led research team has discovered genetic variations that increase the risk of heart attack even when patients are receiving a statin drug like Lipitor or Crestor to lower their blood cholesterol. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2018 Category: International Medicine & Public Health Source Type: news

SECURE-PCI:'Statin Loading' in ACS Doesn't Cut 30-Day Event Risk SECURE-PCI:'Statin Loading' in ACS Doesn't Cut 30-Day Event Risk
But 30-day events dropped significantly after two big atorvastatin doses in one predefined subgroup of the trial's broad acute coronary syndrome population, a secondary but enticing result.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 12, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

This Cholesterol Drug Combination Might Lower Your Risk of Death, Study Finds
(ORLANDO) — A newer cholesterol drug, used with older statin medicines, modestly lowered heart risks and deaths in a big study of heart attack survivors that might persuade insurers to cover the pricey treatment more often. Results on the drug, Praluent, were announced Saturday at an American College of Cardiology conference in Florida. It’s the first time a cholesterol-lowering drug has reduced deaths since statins such as Lipitor and Crestor came out decades ago. “It’s the ultimate outcome; it’s what matters to patients,” said study leader Dr. Philippe Gabriel Steg of Hospital Bichat i...
Source: TIME: Health - March 10, 2018 Category: Consumer Health News Authors: Marilyn Marchione / AP Tags: Uncategorized APH healthytime medicine onetime Source Type: news

Introduction of generic version reduces atorvastatin expenditure
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - March 1, 2018 Category: Drugs & Pharmacology Source Type: news

Dr Reddy's recalls 80,000+ bottles of Atorvastatin from US
The product is being recalled through three separate letters to the drug regulator. Dr Reddy's officials were not immediately available for comment. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 8, 2018 Category: Pharmaceuticals Source Type: news

Those with a high cardiovascular risk profile should eat dark chocolate with olive oil, new study finds
(Natural News) In recent years, the medical community has put a lot of effort into educating people about reducing their cholesterol levels in order to protect their heart health. Of course, those who do have elevated cholesterol levels are often prescribed statin drugs like Lipitor, Zocor and others to lower these levels. In fact, these... (Source: NaturalNews.com)
Source: NaturalNews.com - December 4, 2017 Category: Consumer Health News Source Type: news

Class 2 Medicines Recall: Lipitor (Atorvastatin) 80mg film-coated tablets / Atorvastatin 80mg film-coated tablets, Almus livery
The Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a class 2 medicines recall for specified batches of Lipitor (Atorvastatin) 80mg film-coated tablets / Atorvastatin 80mg film-c (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - November 27, 2017 Category: Drugs & Pharmacology Source Type: news

The effect of local and systemic statin use as an adjunct to non-surgical and surgical periodontal therapy —A systematic review and meta-analysis
ConclusionsSignificant additional clinical and radiographic improvements are obtained after local, but not systemic, statin use as an adjunct to SRP in deep pockets associated with intrabony defects and seemingly with furcation defects; intrasurgical statin application seems similarly beneficial. Confirmation of these results, and especially of the effect size, from other research groups is warranted. (Source: Dental Technology Blog)
Source: Dental Technology Blog - October 20, 2017 Category: Dentistry Source Type: news

Growth inhibition of Candida species and Aspergillus fumigatus by statins.
Statins are a class of drugs widely used for lowering high cholesterol levels through their action on 3-hydroxy-3-methylglutaryl-CoA reductase, a key enzyme in the synthesis of cholesterol. We studied the effects of two major statins,simvastatin and atorvastatin, on five Candida species andAspergillus fumigatus. The statins strongly inhibited the growth of all species, except Candida krusei. Supplementation of Candida albicans and A. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 11, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Atorvastatin Treatment and Risk of Diabetic Foot Infection Atorvastatin Treatment and Risk of Diabetic Foot Infection
Previous atorvastatin use may help protect against the development of diabetic foot infection among adult patients with diabetes, a new study reports.Wounds (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 30, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Does Lipitor Help Rheumatoid Arthritis?
Title: Does Lipitor Help Rheumatoid Arthritis?Category: Doctor's& Expert's views on SymptomsCreated: 8/15/2017 12:00:00 AMLast Editorial Review: 8/15/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 15, 2017 Category: Rheumatology Source Type: news

Give chronic kidney disease patients a statin, doctors urged
20 mg of atorvastatin will help curb their risk of cardiovascular disease, says NICE Related items fromOnMedica Taking statins linked to improved heart structure and function Statins' side effects have been overstated, study suggests Salt intake linked to CVD risk in kidney patients Diet for lowering blood pressure also reduces risk of kidney disease Kidney cancer drug approved for NHS use (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 27, 2017 Category: UK Health Source Type: news

Is Lipitor Safe if I Have Fatty Liver?
Title: Is Lipitor Safe if I Have Fatty Liver?Category: Doctor's& Expert's views on SymptomsCreated: 6/29/2017 12:00:00 AMLast Editorial Review: 6/29/2017 12:00:00 AM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - June 29, 2017 Category: Cardiology Source Type: news

Statins side effects 'have been overstated', says study
Conclusion This is a complex study that provides a plausible explanation for the difference in reports of adverse effects of statins in RCTs and observational studies, some of which have suggested as many as 1 in 5 people get side effects from statins. However, we need to be aware of some limitations and unanswered questions: When people knew they were taking statins, they were more likely to report muscle pain than those not taking statins. But they were less likely to report muscle pain than in the first phase of the study, when they didn't know whether they were taking statins or placebo. We don't know why this is. ...
Source: NHS News Feed - May 3, 2017 Category: Consumer Health News Tags: Medication Heart/lungs Source Type: news

Statins side effects 'have been overstated,' says study
Conclusion This is a complex study that provides a plausible explanation for the difference in reports of adverse effects of statins in RCTs and observational studies, some of which have suggested as many as 1 in 5 people get side effects from statins. However, we need to be aware of some limitations and unanswered questions: When people knew they were taking statins, they were more likely to report muscle pain than those not taking statins. But they were less likely to report muscle pain than in the first phase of the study, when they didn't know whether they were taking statins or placebo. We don't know why this is. ...
Source: NHS News Feed - May 3, 2017 Category: Consumer Health News Tags: Medication Heart/lungs Source Type: news

' Suggestion' of Brain Changes on Statins by fMRI in STOMP'Suggestion' of Brain Changes on Statins by fMRI in STOMP
Despite few differences at cognitive testing for patients on atorvastatin vs placebo in the STOMP substudy,"small but significant" neuronal changes were seen on statins, their meaning unclear.Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 23, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news